Acquisition of Innovative Monoclonal Antibody
Scinai Immunotherapeutics (Nasdaq: SCNI) inked a binding option agreement to purchase Italian biotech company Pincell srl, taking an interest in PC111, a monoclonal antibody in development for severe dermatological conditions like Pemphigus, Stevens-Johnson Syndrome (SJS),...
Boohoo rebrands as Debenhams to revive struggling youth fashion labels. Sales dropped 21% to £947m due to competition and secondhand trends. Cost-cutting measures and portfolio review underway.
The UK stock market in 2025 combines growth in technology, healthcare, and renewable energy sectors, with risks from high interest rates and geopolitical tensions. Caution is advised due to ongoing uncertainties.
2024 saw key UK insurance rulings on COVID-19 business interruptions and jurisdictional challenges in high-risk regions, emphasizing the need for clear policy wordings and robust legal strategies.
